3 Big Pharma Stocks to Buy, 3 to Avoid

Big Pharma stocks are under pressure as regulation threatens to curb drug prices and tax driven mergers are intercepted by the treasury. More 

5 Dividend Stocks Starting a Multi-Decade Bull Market

A 'niche" bull run is in the market that's going to continue for the long term. Healthcare stocks are solid long-term portfolio dividend stocks to buy More 

These 54 Big Blue Chips Are On the Move

During these busy times it pays to stay on top of the latest blue chip opportunities. Today's blog post is a great place to start with these updated ratings More 

Gilead Sciences, Inc. (GILD) Buys Nimbus Therapeutics Subsidiary for $1.2B

Gilead Sciences has announced that it will be acquiring Nimbus Therapeutics' Nimbus Apollo, Inc. subsidiary for up to $1.2 billion. More 

3 Biotech Stocks on the Verge of an Overdue Run (AMGN, GILD, REGN)

Biotech stocks are making a comeback, with these three biotech beauties boasting bottoming patterns suggesting the time to strike is at hand. More 

Why Freeport-McMoRan Inc (FCX), Gilead Sciences, Inc. (GILD) and Tesla Motors Inc (TSLA) Are 3 of Today’s Worst Stocks

Gilead Sciences, Inc. (GILD), Freeport-McMoRan (FCX) and Tesla Motors (TSLA) never even had a prayer of gains on Wednesday. More 

Gilead Sciences, Inc.: GILD Could Squeeze the Bears From Here

Gilead Sciences enjoyed a rally Monday along with the rest of the biotech sector. This breakout could be followed up by a short squeeze in GILD stock. More